Rodin Therapeutics Appoints CEO
This article was originally published in Scrip
Rodin Therapeutics has appointed Adam J. Rosenberg CEO and a member of its board. Rosenberg is the co-founder of various companies including Clean Membranes, where he was also on the board; Faber Law Group; and most recently, Teleos Therapeutics for which he was also director and CEO. He has also served in interim executive roles with various healthcare and biotech companies including Brightstar (acquired by SoftBank), and served on the advisory board of Gecko Health Innovations (acquired by Teva Pharmaceuticals).